 | Form 4 Filings | Insider Buys | Significant Buys | Penny Stocks Insider Buying | Insider Sales |
| Insider Buy Sell Ratios | Stock Options | Insider Trading Stock Screener | Insider Trading Graph View | Insider Watch |
Insider Trading - Altimmune Inc. (ALT)
| | "Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise" - Peter Lynch What is insider trading>> |
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2019-09-05 Purchase | 2019-09-05 5:04 pm | Altimmune Inc. | ALT | Garg Vipin K CEO | 20,000 | $2.1 | $42,000 | 342,907 (Direct) | View |
| 2018-10-09 Purchase | 2018-10-11 4:18 pm | Altimmune Inc. | ALT | Pisano Wayne Director | 2,000 | $4.59 | $9,180 | 2,000 (Direct) | View |
| 2018-05-25 Purchase | 2018-05-29 6:17 pm | Altimmune Inc. | ALT | Enright William CEO | 1,300 | $0.5076 | $660 | 365,839 (Direct) | View |
| 2017-06-06 Purchase | 2018-02-23 4:21 pm | Altimmune Inc. | ALT | Roberts M Scot Chief Scientific Officer | 449 | $4.42 | $1,985 | 449 (Indirect) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2020-01-02 Option Award | 2020-01-03 5:06 pm | N/A 2030-01-02 | Altimmune Inc. | ALT | Roberts M Scot Chief Scientific Officer | 61,400 | $1.921 | 61,400 (Direct) | View |
| 2020-01-02 Option Award | 2020-01-03 5:02 pm | N/A 2030-01-02 | Altimmune Inc. | ALT | Garg Vipin K CEO | 149,500 | $1.921 | 149,500 (Direct) | View |
| 2020-01-02 Option Award | 2020-01-03 5:01 pm | N/A 2030-01-02 | Altimmune Inc. | ALT | Harris Matthew Scott Chief Medical Officer | 61,400 | $1.921 | 61,400 (Direct) | View |
| 2020-01-02 Option Award | 2020-01-03 5:00 pm | N/A 2030-01-02 | Altimmune Inc. | ALT | Brown William Michael CFO | 61,400 | $1.921 | 61,400 (Direct) | View |
| 2019-12-30 Tax Withholding | 2020-01-02 5:00 pm | N/A N/A | Altimmune Inc. | ALT | Garg Vipin K CEO | 1,999 | $1.8 | 316,932 (Direct) | View |
| 2019-11-30 Tax Withholding | 2019-12-03 7:00 pm | N/A N/A | Altimmune Inc. | ALT | Garg Vipin K CEO | 23,976 | $1.82 | 318,931 (Direct) | View |
| 2019-09-09 Option Award | 2019-09-11 4:07 pm | N/A 2029-09-09 | Altimmune Inc. | ALT | Harris Matthew Scott Chief Medical Officer | 107,000 | $2.13 | 107,000 (Direct) | View |
| 2019-06-17 Option Award | 2019-06-19 4:01 pm | N/A 2024-06-17 | Altimmune Inc. | ALT | Tasker Sybil Chief Medical Officer | 20,000 | $2.46 | 20,000 (Direct) | View |
| 2019-06-10 Option Award | 2019-06-12 4:50 pm | N/A 2029-06-10 | Altimmune Inc. | ALT | Brown William Michael CFO | 50,000 | $2.34 | 50,000 (Direct) | View |
| 2019-03-26 Option Award | 2019-03-27 5:49 pm | N/A 2029-03-26 | Altimmune Inc. | ALT | Tasker Sybil Chief Medical Officer | 38,000 | $2.95 | 38,000 (Direct) | View |
| 2019-03-26 Option Award | 2019-03-27 5:46 pm | N/A 2029-03-26 | Altimmune Inc. | ALT | Roberts M Scot Chief Scientific Officer | 38,000 | $2.95 | 38,000 (Direct) | View |
| 2019-01-02 Option Award | 2019-01-04 5:31 pm | N/A 2024-01-02 | Altimmune Inc. | ALT | Brown William Michael CFO | 30,000 | $2.6 | 30,000 (Direct) | View |
| 2019-01-02 Option Award | 2019-01-04 5:22 pm | N/A 2029-01-02 | Altimmune Inc. | ALT | SAYARE MITCHEL Director | 30,000 | $2.6 | 30,000 (Direct) | View |
| 2019-01-02 Option Award | 2019-01-04 5:18 pm | N/A 2029-01-02 | Altimmune Inc. | ALT | Schafer Klaus Director | 20,000 | $2.6 | 20,000 (Direct) | View |
| 2019-01-02 Option Award | 2019-01-04 5:15 pm | N/A 2029-01-02 | Altimmune Inc. | ALT | Hodges Philip Director | 20,000 | $2.6 | 20,000 (Direct) | View |
| 2019-01-02 Option Award | 2019-01-04 5:11 pm | N/A 2029-01-02 | Altimmune Inc. | ALT | GILL JOHN Director | 20,000 | $2.6 | 20,000 (Direct) | View |
| 2019-01-02 Option Award | 2019-01-04 5:07 pm | N/A 2029-01-02 | Altimmune Inc. | ALT | Drutz David Director | 20,000 | $2.6 | 20,000 (Direct) | View |
| 2019-01-02 Option Award | 2019-01-04 5:03 pm | N/A 2029-01-02 | Altimmune Inc. | ALT | Pisano Wayne Director | 20,000 | $2.6 | 20,000 (Direct) | View |
| 2019-01-02 Option Award | 2019-01-04 4:59 pm | N/A 2029-01-02 | Altimmune Inc. | ALT | Tasker Sybil Chief Medical Officer | 30,000 | $2.6 | 30,000 (Direct) | View |
| 2019-01-02 Option Award | 2019-01-04 4:58 pm | N/A 2029-01-02 | Altimmune Inc. | ALT | Roberts M Scot Chief Scientific Officer | 30,000 | $2.6 | 30,000 (Direct) | View |
| 2018-11-30 Option Award | 2018-12-04 4:08 pm | N/A N/A | Altimmune Inc. | ALT | Garg Vipin K CEO | 322,907 | $0 | 111,421 (Direct) | View |
| 2018-11-30 Option Award | 2018-12-04 4:08 pm | N/A 2028-11-30 | Altimmune Inc. | ALT | Garg Vipin K CEO | 211,486 | $3.59 | 111,421 (Direct) | View |
| 2018-11-30 Option Award | 2018-12-04 4:08 pm | N/A 2028-11-30 | Altimmune Inc. | ALT | Garg Vipin K CEO | 111,421 | $3.59 | 111,421 (Direct) | View |
| 2018-09-12 Other | 2018-09-14 09:14 am | N/A N/A | Altimmune Inc. | ALT | Novartis Bioventures Ltd NOVARTIS AG 10% Owner | 2,069,993 | $0 | 0 (Indirect) | View |
| 2018-09-12 Other | 2018-09-14 09:14 am | 2017-08-21 2022-08-21 | Altimmune Inc. | ALT | Novartis Bioventures Ltd NOVARTIS AG 10% Owner | 465,086 | $2.67 | 0 (Indirect) | View |
| 2018-07-11 Other | 2018-07-13 4:02 pm | N/A N/A | Altimmune Inc. | ALT | Novartis Bioventures Ltd NOVARTIS AG 10% Owner | 663,346 | $0 | 0 (Indirect) | View |
| 2018-07-11 Other | 2018-07-13 4:02 pm | 2017-08-21 2018-08-15 | Altimmune Inc. | ALT | Novartis Bioventures Ltd NOVARTIS AG 10% Owner | 345 | $940 | 0 (Indirect) | View |
| 2018-06-15 Other | 2018-06-19 5:03 pm | N/A N/A | Altimmune Inc. | ALT | Novartis Bioventures Ltd NOVARTIS AG 10% Owner | 14,449 | $0 | 5,611,806 (Indirect) | View |
| 2018-06-13 Other | 2018-06-15 5:11 pm | N/A N/A | Altimmune Inc. | ALT | Novartis Bioventures Ltd NOVARTIS AG 10% Owner | 720,878 | $0 | 345 (Indirect) | View |
| 2018-06-13 Other | 2018-06-15 5:11 pm | 2017-08-21 2018-08-15 | Altimmune Inc. | ALT | Novartis Bioventures Ltd NOVARTIS AG 10% Owner | 345 | $2.67 | 345 (Indirect) | View |
| 2018-05-21 Option Award | 2018-05-23 5:26 pm | N/A 2028-05-21 | Altimmune Inc. | ALT | Tasker Sybil Chief Medical Officer | 50,016 | $0.445 | 50,016 (Direct) | View |
| 2018-05-21 Exercise | 2018-05-23 5:23 pm | N/A N/A | Altimmune Inc. | ALT | Roberts M Scot Chief Scientific Officer | 55,120 | $0.08 | 0 (Direct) | View |
| 2018-05-21 Option Award | 2018-05-23 5:23 pm | N/A 2028-05-21 | Altimmune Inc. | ALT | Roberts M Scot Chief Scientific Officer | 50,016 | $0.445 | 0 (Direct) | View |
| 2018-05-21 Exercise | 2018-05-23 5:23 pm | 2017-05-04 2022-12-05 | Altimmune Inc. | ALT | Roberts M Scot Chief Scientific Officer | 55,120 | $0.08 | 0 (Direct) | View |
| 2018-05-21 Option Award | 2018-05-23 5:21 pm | N/A 2028-05-21 | Altimmune Inc. | ALT | Enright William CEO | 103,158 | $0.445 | 103,158 (Direct) | View |
| 2018-05-15 Other | 2018-05-17 4:07 pm | N/A N/A | Altimmune Inc. | ALT | Novartis Bioventures Ltd NOVARTIS AG 10% Owner | 274,703 | $0 | 690 (Indirect) | View |
| 2018-05-15 Other | 2018-05-17 4:07 pm | N/A N/A | Altimmune Inc. | ALT | Novartis Bioventures Ltd NOVARTIS AG 10% Owner | 767,728 | $0 | 690 (Indirect) | View |
| 2018-05-15 Other | 2018-05-17 4:07 pm | 2017-08-21 2018-08-15 | Altimmune Inc. | ALT | Novartis Bioventures Ltd NOVARTIS AG 10% Owner | 345 | $2.67 | 690 (Indirect) | View |
| 2018-04-16 Other | 2018-04-18 4:56 pm | N/A N/A | Altimmune Inc. | ALT | Novartis Bioventures Ltd NOVARTIS AG 10% Owner | 482,907 | $0 | 1,035 (Indirect) | View |
| 2018-04-16 Other | 2018-04-18 4:56 pm | N/A N/A | Altimmune Inc. | ALT | Novartis Bioventures Ltd NOVARTIS AG 10% Owner | 217,159 | $0 | 1,035 (Indirect) | View |
| 2018-04-16 Other | 2018-04-18 4:56 pm | 2017-08-21 2018-08-15 | Altimmune Inc. | ALT | Novartis Bioventures Ltd NOVARTIS AG 10% Owner | 345 | $2.67 | 1,035 (Indirect) | View |
| 2018-04-05 Option Award | 2018-04-06 8:27 pm | N/A 2028-04-05 | Altimmune Inc. | ALT | SAYARE MITCHEL Director | 35,000 | $0.95 | 35,000 (Direct) | View |
| 2018-03-15 Other | 2018-03-19 4:06 pm | N/A N/A | Altimmune Inc. | ALT | Novartis Bioventures Ltd NOVARTIS AG 10% Owner | 261,969 | $0 | 1,380 (Indirect) | View |
| 2018-03-15 Other | 2018-03-19 4:06 pm | 2017-08-21 2018-08-15 | Altimmune Inc. | ALT | Novartis Bioventures Ltd NOVARTIS AG 10% Owner | 345 | $2.67 | 1,380 (Indirect) | View |
| 2018-02-13 Other | 2018-02-15 4:49 pm | N/A N/A | Altimmune Inc. | ALT | Truffle Capital S.A.S. 10% Owner | 17,789 | $0 | 114 (Indirect) | View |
| 2018-02-13 Other | 2018-02-15 4:49 pm | N/A N/A | Altimmune Inc. | ALT | Truffle Capital S.A.S. 10% Owner | 23,719 | $0 | 114 (Indirect) | View |
| 2018-02-13 Other | 2018-02-15 4:49 pm | N/A N/A | Altimmune Inc. | ALT | Truffle Capital S.A.S. 10% Owner | 17,789 | $0 | 114 (Indirect) | View |
| 2018-02-13 Other | 2018-02-15 4:49 pm | N/A N/A | Altimmune Inc. | ALT | Truffle Capital S.A.S. 10% Owner | 4,483 | $0 | 114 (Indirect) | View |
| 2018-02-13 Other | 2018-02-15 4:49 pm | N/A N/A | Altimmune Inc. | ALT | Truffle Capital S.A.S. 10% Owner | 5,977 | $0 | 114 (Indirect) | View |
| 2018-02-13 Other | 2018-02-15 4:49 pm | N/A N/A | Altimmune Inc. | ALT | Truffle Capital S.A.S. 10% Owner | 4,483 | $0 | 114 (Indirect) | View |
| 2018-02-13 Other | 2018-02-15 4:49 pm | 2017-08-21 2018-08-15 | Altimmune Inc. | ALT | Truffle Capital S.A.S. 10% Owner | 23 | $2.67 | 114 (Indirect) | View |
| 2018-02-13 Other | 2018-02-15 4:49 pm | 2017-08-21 2018-08-15 | Altimmune Inc. | ALT | Truffle Capital S.A.S. 10% Owner | 30 | $2.67 | 114 (Indirect) | View |
| 2018-02-13 Other | 2018-02-15 4:49 pm | 2017-08-21 2018-08-15 | Altimmune Inc. | ALT | Truffle Capital S.A.S. 10% Owner | 23 | $2.67 | 114 (Indirect) | View |
| 2018-02-13 Other | 2018-02-15 4:34 pm | N/A N/A | Altimmune Inc. | ALT | Novartis Bioventures Ltd NOVARTIS AG 10% Owner | 269,527 | $0 | 1,725 (Indirect) | View |
| 2018-02-13 Other | 2018-02-15 4:34 pm | N/A N/A | Altimmune Inc. | ALT | Novartis Bioventures Ltd NOVARTIS AG 10% Owner | 67,925 | $0 | 1,725 (Indirect) | View |
| 2018-02-13 Other | 2018-02-15 4:34 pm | 2017-08-21 2018-08-15 | Altimmune Inc. | ALT | Novartis Bioventures Ltd NOVARTIS AG 10% Owner | 345 | $2.67 | 1,725 (Indirect) | View |